Archive: Blog
- November 10, 2026
Oral and Injectable GLP-1 Market Growth: What Plan Sponsors Need to Know
Read MoreThe GLP-1 market has expanded rapidly in recent years, and the introduction of oral weight-loss medications is creating another wave of growth. Here’s what plan sponsors need to know.
- November 9, 2026
Drug Cost Management for New Drugs | Innovative Rx Strategies
Read MoreThe prescription drug landscape is constantly evolving with new medications entering the market every year. So how should plan sponsors manage cost?
- October 26, 2026
Rx History: The Rise of GLP-1s
Read MoreLay the foundation for understanding the high-cost drugs impacting pharmacy benefit plans today with this extensive history of GLP-1s.
- October 22, 2026
PBM Audit: What Your PBM Contract Isn’t Telling You
Read MorePBM audits and annual financial reconciliations are often mentioned in the same breath, but they are not interchangeable. Each plays a distinct role in protecting your pharmacy spend and holding your PBM accountable.
- October 14, 2026
Annual Market Checks: How to Keep Your PBM Contract Competitive
Read MoreLearn how annual market checks help self-funded employers benchmark PBM pricing, validate contract performance and uncover savings — without a full RFP.
- October 13, 2026
Why Anti-Inflammatory Drug Spending Keeps Rising Despite Biosimilars
Read MoreBiosimilars are cutting some costs, but newer anti-inflammatory biologics are driving specialty spend higher. See what employers need to know for 2027 planning.
- October 12, 2026
ERISA Preemption & State PBM Legislation: What Self-Funded Plans Should Watch (2026)
Read MoreHealth care legislation is always changing, from prescription drug coverage to transparency requirements and PBM regulation. So, what should self-funded employers know?
- September 30, 2026
Why Annual Financial Reconciliation is Critical to Plan Performance
Read MoreThe complexity of pharmacy benefits manager (PBM) contracts can make it difficult for employers to know exactly where their plan dollars are going and whether their PBM is delivering the full value promised in the contract.
- September 2, 2026
Steps for Improving Stop-Loss Insurance Renewals in 2026
Read MoreIt’s stop-loss insurance renewal season, and for self-funded employers, the stakes can be high with regard to the impact on health care costs for the upcoming plan year. The decisions employers make throughout the plan year influence their position when …
- August 12, 2026
Xeljanz® Generics Hit the Market, Driving $76,000 Drop in Drug Cost
Read MoreThe recent launch of generic versions of Xeljanz is a striking example of the savings that can be generated when competitive drugs enter the market.
- July 9, 2026
Mute & Obey Is Dead: The Future of Virtual Engagement
Read MoreDiscover key takeaways from a standout SHRM26 session on remote work, including how to design more engaging, interactive, and human virtual experiences.
- June 18, 2026
Why Financial Institutions are Leaning into Pharmacy Strategy
Read MoreAs a leading pharmacy benefits consultant, Innovative Rx Strategies continuously monitors emerging trends and priorities across the industry. In our latest survey, we found that financial institutions were overrepresented in the conversations that followed.










